C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2004
11/24/2004	CN1176942C Amino acid polypeptide with strong membrane-inserting capability
11/24/2004	CN1176577C Nucleotide series of coded insecticidal crystalline protein and its application
11/23/2004	US6822140 Compositions and methods for fumonisin detoxification
11/23/2004	US6822084 For food/feeds/cosmetics/drugs; genetic engineering
11/23/2004	US6822083 TSA305 gene
11/23/2004	US6822082 Polynucleotides for mammalian secreted protein, Z1055G2P
11/23/2004	US6822080 For identification/cloning/drug screening; enzyme inhibitors
11/23/2004	US6822079 Regulates plant nitrogen metabolism; engineered plants that overexpress or underexpress p-pii regulatory protein may have increased nitrogen assimilation capacity
11/23/2004	US6822078 Compounds for use in the evaluation of humans inflammatory and immunological defects
11/23/2004	US6822077 Altering ku80 levels in plants; recobinant expression cassettes
11/23/2004	US6822075 Protein for use in the diagnosis and treatment of autoimmune, cancer and viral disorders
11/23/2004	US6822073 Immunology diagnosis analyzing; using computer
11/23/2004	US6822072 For diagnostics/forensics/gene therapy/chromosome mapping; expression vector design/secretion
11/23/2004	US6822071 Polypeptides from Chlamydia pneumoniae and their use in the diagnosis, prevention and treatment of disease
11/23/2004	US6822070 Truncated CRAF1 inhibits CD40 signaling
11/23/2004	US6821954 Compounds and uses thereof in treating bone disorders
11/23/2004	US6821952 Peptide-based compounds having light-emitting moieties to monitor peptide, cytokine, drug, and hormone receptors at the cellular level
11/23/2004	US6821950 Antagonist of a g protein-coupled receptor, which has no agonist activity, and which has a cyclic or constrained acyclic structure
11/23/2004	US6821949 Long lasting synthetic glucagon-like peptide (GLP-1)
11/23/2004	US6821946 Treating nerve damage; administer insulin like growth factor isoform to human, monitor response of damaged nerves
11/23/2004	US6821945 Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
11/23/2004	US6821775 Viral vector encoding pigment epithelium-derived factor
11/23/2004	US6821774 Compositions and methods for increasing cholesterol efflux and raising HDL using ATP binding cassette transporter ABC1
11/23/2004	US6821769 Nucleotide sequences coding polypeptide for use in the prevention of bacterial infections
11/23/2004	US6821767 Androgen receptor proteins, recombinant DNA molecules coding for such, and use of such compositions
11/23/2004	US6821764 Genes encoding sulfate assimilation proteins
11/23/2004	US6821759 Methods of performing homologous recombination based modification of nucleic acids in recombination deficient cells and use of the modified nucleic acid products thereof
11/23/2004	US6821754 Staphylococcus aureus genes and polypeptides
11/23/2004	US6821750 ABCG8 vectors, host cells, and method of making
11/23/2004	US6821749 Methods of producing carotenoids using DNA molecules encoding isopentenyl pyrophosphate isomerase
11/23/2004	US6821743 Membrane protein for use in controlling vasodilation
11/23/2004	US6821742 Conformational and topological protein regulation
11/23/2004	US6821736 Human cellular inhibitor of apoptosis proteins (c-iap1/2); binding tumor necrosis factor receptor associated factor (traf); for automatic high throughput drug screening/diagnosis/therapy
11/23/2004	US6821735 Protein involved in abscisic acid signalling
11/23/2004	US6821728 Screening system
11/23/2004	US6821723 Polypeptide mimics the intermediate state of gp41 and is capable of inducing antibodies which neutralize primary isolates of hiv
11/23/2004	US6821522 Administering to the mammalian host a composition comprising a multivalent nkg2d-binding agent to a tumor expressing native nkg2d
11/23/2004	US6821521 Multicomponent meningococcal vaccine
11/23/2004	US6821519 Comprises polypeptide for detecting viral infection; immunoassays; immunostimulant
11/23/2004	US6821518 Polypeptides encoded by nucleotide sequences preferentially expressed in lung tumor may be used in vaccines and pharmaceutical compositions for treatment and diagnosis of lung cancer
11/23/2004	US6821517 Compositions and methods for enhancing immune responses mediated by antigen-presenting cells
11/23/2004	US6821511 Transducing cell; incubate cells with nucleotide sequences, insert cells into mammals, monitor mammals for phenotypic adjustment
11/23/2004	CA2265587C Cyanidin compositions and therapeutic and diagnostic uses therefor
11/23/2004	CA2131709C Immune-enhancing agent for therapeutic use in immunocompromised hosts
11/23/2004	CA2116026C Hepatitis c assay utilizing recombinant antigens to c-100 region
11/23/2004	CA2012482C Hepatitis c diagnostics and vaccines
11/18/2004	WO2004099784A2 Method for determining a tissue degradation process by detection of fibromodulin neoepitopes
11/18/2004	WO2004099782A2 Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor gpr39 (gpr39)
11/18/2004	WO2004099781A2 Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor rdc1 (rdc1)
11/18/2004	WO2004099771A1 A new specific epitope based immunological diagnosis of tuberculosis
11/18/2004	WO2004099436A2 Structural and cytoskeleton-associated proteins
11/18/2004	WO2004099423A1 Vp2-modified raav vectors and uses thereof
11/18/2004	WO2004099422A2 Adenovirus particles with enhanced infectivity of dendritic cells and particles with decreased infectivity of hepatocytes
11/18/2004	WO2004099421A1 Multiple gene transcription activity determining sysyem
11/18/2004	WO2004099419A2 Methods and compositions for identifying modulators of g protein-coupled receptors
11/18/2004	WO2004099418A1 Fused protein
11/18/2004	WO2004099417A1 Genetic sequences of plant pathogen avirulence genes and uses therefor
11/18/2004	WO2004099416A1 Dna fragment specific to cytoplasmic male sterile pepper and use thereof
11/18/2004	WO2004099415A1 A new stress-resistance transcription factor (capf1) gene, its protein and a transfected plant by the gene
11/18/2004	WO2004099412A1 Nucleic acid molecules differentially expressed in animals exhibiting behavioural disorders
11/18/2004	WO2004099408A1 Novel protein and dna coding for the same
11/18/2004	WO2004099406A1 Method of purifying modified acarian main allergen
11/18/2004	WO2004099405A1 Human blood proteins expressed in monocot seeds
11/18/2004	WO2004099390A2 Molecules for disease detection and treatment
11/18/2004	WO2004099388A2 Cbl-b polypeptides, complexes and related methods
11/18/2004	WO2004099386A2 Gene silencing by systemic rna interference
11/18/2004	WO2004099376A2 Assays using amyloid precursor proteins with modified beta-secretase cleavage sites to monitor beta-secretase activity
11/18/2004	WO2004099367A2 Methods for producing zinc finger proteins that bind to extended dna target sequences
11/18/2004	WO2004099365A2 Transcription factor gene induced by water deficit conditions and abscisic acid from helianthus annuus, promoter and transgenic plants
11/18/2004	WO2004099254A2 Activation of recombinant diphtheria toxin fusion proteins by specific proteases highly expressed on the surface of tumor cells
11/18/2004	WO2004099253A1 Method of detecting probnp with a monoclonal antibody binding to the amino acid 41-46
11/18/2004	WO2004099252A1 Method of detecting native probnp with amonoclonal antibody binding to the amino acids 38-44
11/18/2004	WO2004099248A2 Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor agtr2 (agtr2)
11/18/2004	WO2004099247A2 Synthetic gene encoding human carcinoembryonic antigen and uses thereof
11/18/2004	WO2004099246A2 Peptides for use in treating obesity
11/18/2004	WO2004099245A1 Stabilised interferon-ϝ
11/18/2004	WO2004099244A2 Immunogenic human tnf alpha analogues with reduced cytotoxicity and methods of their preparation
11/18/2004	WO2004099243A2 Truncated forms of human dbf4, complexes with their interacting partners and methods for identification of inhibitors thereof
11/18/2004	WO2004099242A2 Streptococcus agalactiae antigens i + ii
11/18/2004	WO2004099241A1 Hepatitis c virus ns5b polymerase inhibitor binding pocket
11/18/2004	WO2004099240A2 Peptides and mixtures thereof for use in the detection of severe acute respiratory syndrome-associated coronavirus (sars)
11/18/2004	WO2004099238A1 NOVEL mu-CONOTOXIN PEPTIDES
11/18/2004	WO2004099235A2 Bacteriocins and novel bacterial strains
11/18/2004	WO2004099232A2 Selective r-cadherin antagonists and methods
11/18/2004	WO2004099231A2 Glycopegylation methods and proteins/peptides produced by the methods
11/18/2004	WO2004098639A1 METHOD OF CONTROLLING TGFβ-ORIGIN APOPTOSIS
11/18/2004	WO2004098536A2 Anti-viral activity of cathelicidin peptides
11/18/2004	WO2004098526A2 Anti-cancer dna vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein
11/18/2004	WO2004098515A2 Nucleic acids and corresponding proteins entitled 109p1d4 useful in treatment and detection of cancer
11/18/2004	WO2004098502A2 Cngh0010 specific polynucleotides, polypeptides, antibodies, compositions, methods and uses.
11/18/2004	WO2004098497A2 Cd4+ human papillomavirus (hpv) epitopes
11/18/2004	WO2004098492A2 Trans-golgi network-associated processes, methods and compositions related thereto
11/18/2004	WO2004098310A1 Peptides having an ace inhibiting effect
11/18/2004	WO2004098309A1 Hydrolysed casein product comprising tripeptides ipp and/ or vpp
11/18/2004	WO2004098282A2 Nematode atp synthase subunit e-like sequences
11/18/2004	WO2004092214A3 Affinity purification system using troponin molecules as affinity ligands
11/18/2004	WO2004087930A8 Adenovirus replication-competent vectors expressing trail
11/18/2004	WO2004087752A3 Spinster-like protein genes, expression products, non-human animal model: uses in human metabolic disorders
11/18/2004	WO2004087622A3 Gpr54 receptor agonist and antagonist useful for the treatmentt of gonadotropin related diseases
11/18/2004	WO2004085648A3 Nogo receptor binding protein

1 ... 1300 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 ... 2916